Primary Citation PubMed: 23217210
Citations in PubMed
This linkout lists citations, indexed by PubMed, to the Primary Citation for this PDB ID.
Data mentions are occurrences of PDB IDs in the full text articles from the
PubMedCentral Open Access Subset
of currently about 1 million articles. For each article, the sentences containing the PDB ID are listed.
Article titles can be filtered by keywords and sorted by year.
A comparison of the ability of rilpivirine (TMC278) and selected analogues to inhibit clinically relevant HIV-1 reverse transcriptase mutants.
(2012) Retrovirology 9
PubMed: 23217210 | PubMedCentral: PMC3549755 | DOI: 10.1186/1742-4690-9-99
Models of complexes with 16 and 21 were based on the crystal structures presented in the current work (PDB IDs 4I2P and 4I2Q, respectively).
Table 1 X-ray data and refinement statistics HIV-1 WT RT/16 K103N/Y181C mutant HIV-1 RT/21 Protein Data Bank (PDB) accession code 4I2P 4I2Q Space group C2 C2 Cell constants (a, b, c in Å; β in º) 162.65, 72.99, 109.50; 100.59 162.60, 72.95, 108.54; 100.70 Resolution range (Å) 50.00 – 2.30 50.00 – 2.70 Completeness (%) 98.8 99.2 R merge 0.085 0.084 Average I/σI 15.0 16.5 Sigma cut-off (I) |I| < −3.0σ |I| < −3.0σ Refinement Statistics Total no.
Publication Year: 2012
The RCSB PDB (citation) is managed by two members of the Research Collaboratory for Structural Bioinformatics:
RCSB PDB is a member of the
The RCSB PDB is funded by a grant (DBI-1338415) from the
National Science Foundation, the
National Institutes of Health, and the
US Department of Energy.